Company Filing History:
Years Active: 1991
Title: The Innovations of Karen G Burnett
Introduction
Karen G Burnett is a notable inventor based in San Diego, California. She has made significant contributions to the field of biotechnology, particularly in the development of therapeutic compositions. Her work focuses on enhancing the efficacy of antiviral treatments through innovative approaches.
Latest Patents
Karen G Burnett holds a patent for "Interferon antibody therapeutic compositions having an extended serum." This invention involves a complex of alpha-interferon with monoclonal antibody complexes that maintain the antiviral activity of the interferon. The serum half-life of the interferon administered as this complex is substantially increased compared to that of alpha-interferon administered alone. This advancement has the potential to improve treatment outcomes for patients requiring antiviral therapies.
Career Highlights
Throughout her career, Karen has been associated with Hybritech Incorporated, a company known for its pioneering work in biotechnology. Her role at Hybritech has allowed her to contribute to groundbreaking research and development in the field.
Collaborations
Karen has collaborated with esteemed colleagues such as James M Frincke and Barbara W Unger. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Karen G Burnett's contributions to biotechnology through her patent and work at Hybritech Incorporated highlight her role as a significant inventor in the field. Her innovative approaches to antiviral therapies continue to pave the way for advancements in medical treatments.